Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients.

Fiche publication

Date publication

mai 2020

Journal

Joint bone spine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOULAHDOUR Hatem

Tous les auteurs :
Wendling D, Sondag M, Giraud N, Chouk M, Boulahdour H, Prati C, Verhoeven F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32007650

Résumé

18F-fluoro deoxy glucose PET scanner (18F-FDG-PET-CT) has shown its interest in the diagnosis of polymyalgia rheumatica (PMR) and makes possible to evaluate the metabolic activity of the entire musculoskeletal system and in particular muscular structures. The purpose of this study was to evaluate muscle involvement using 18F-FDG-PET-CT in the case of PMR, compared to a non PMR population.